SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-171457
Filing Date
2020-06-17
Accepted
2020-06-17 17:14:04
Documents
6
Period of Report
2020-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942122d8k.htm 8-K 25249
2 EX-1.1 d942122dex11.htm EX-1.1 211013
3 EX-5.1 d942122dex51.htm EX-5.1 10535
4 EX-99.1 d942122dex991.htm EX-99.1 8945
5 GRAPHIC g942122g0617113312584.jpg GRAPHIC 2021
6 GRAPHIC g942122g0617113549318.jpg GRAPHIC 3929
  Complete submission text file 0001193125-20-171457.txt   265447
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 20970499
SIC: 2834 Pharmaceutical Preparations